selected publications
-
Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma.
European urology.
2020
Academic Article
GET IT
Times cited: 30 -
Escape from nonsense-mediated decay associates with anti-tumor immunogenicity.
Nature communications.
2020
Academic Article
GET IT
Times cited: 65 -
Adjuvant Chemotherapy With Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2020
Academic Article
GET IT
Times cited: 15 -
Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes.
Cell reports.
2018
Academic Article
GET IT
Times cited: 69 -
Controversies in the Management of Clinical Stage I Seminoma: Carboplatin a Decade in-Time to Start Backing Out.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2018
Academic Article
GET IT
Times cited: 14 -
Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma.
Leukemia & lymphoma.
2017
Article
GET IT
Times cited: 9 -
Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis.
PLoS medicine.
2017
Academic Article
GET IT
Times cited: 251 -
Systemic, perioperative management of muscle-invasive bladder cancer and future horizons.
Nature reviews. Clinical oncology.
2016
Information Resource
GET IT
Times cited: 94 -
The Management of Advanced Germ Cell Tumors in 2016: The Memorial Sloan Kettering Approach.
Oncology (Williston Park, N.Y.).
2016
Review
GET IT
Times cited: 10 -
The Role of Neoadjuvant Trials in Drug Development for Solid Tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2016
Information Resource
GET IT
Times cited: 29 -
Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation.
The Journal of clinical investigation.
2015
Academic Article
GET IT
Times cited: 133 -
CTLA-4 antibodies: new directions, new combinations.
Oncology (Williston Park, N.Y.).
2014
Information Resource
GET IT
Times cited: 20 -
Pegylation of high-density lipoprotein decreases plasma clearance and enhances antiatherogenic activity.
Circulation research.
2013
Academic Article
GET IT
Times cited: 51 -
Incidence, epidemiology, and prognosis of residual pulmonary hypertension after mitral valve repair for degenerative mitral regurgitation.
The American journal of cardiology.
2011
Academic Article
GET IT
Times cited: 15